Publication Details
Complete pathological response after neoadjuvant long-course chemoradiotherapy for rectal cancer and its relationship to the degree of T3 mesorectal invasion
Wilkins S, Haydon A, Porter I, Oliva K, Staples M, Carne P, McMurrick P, Bell S
(2016),
Dis Colon Rectum,
59(5),
Predictors and rate of adjuvant radiation therapy following radical prostatectomy: a report from the Prostate Cancer Registry
Daniels CP, Millar JL, Spelman T, Sengupta S, Evans SM
(2016),
J Med Imaging Radiat Oncol,
60(2),
Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry
Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL
(2016),
BJU Int,
118(4),
Dose and gamma-ray spectra from neutron-induced radioactivity in medical linear accelerators following high-energy total body irradiation
Keehan S, Taylor ML, Smith RL, Dunn L, Kron T, Franich RD
(2016),
Radiat Prot Dosim,
172(4),
Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
So K, Smith RE, Davis SR
(2016),
ANZ J Surg,
86(9),
Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer
Ung KA, Campbell BA, Duplan D, Ball D, David S
(2016),
Asia Pac J Clin Oncol,
12(2),
Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Woodford K, Senthi S
(2015),
Transl Lung Cancer Res,
4(5),
619-22;627–8
Characterising an aluminium oxide dosimetry system
Conheady CF, Gagliardi FM, Ackerly T
(2015),
Australas Phys Eng Sci Med,
38(3),
447-53
High resolution 3D imaging of synchrotron generated microbeams
Gagliardi FM, Cornelius I, Blencowe A, Franich RD, Geso M
(2015),
Med Phys,
42(12),
6973-86
Determination of dose enhancement caused by gold-nanoparticles irradiated with proton, X-rays (kV and MV) and electron beams, using alanine/EPR dosimeters
Smith CL, Ackerly T, Best SP, Gagliardi F, Little PJ, McCorkell G, Sale CA, Tsunei Y, Tominaga T, Volaric SS, Geso M
(2015),
Radiat Meas,
82,
122-8
Monitoring quality of care in men diagnosed with prostate cancer: developing consensus quality indicators using modified-Delphi methodology
Evans SM, Lin D, Millar J, Murphy D, Dean J
(2015),
J Epidemiol Prev Med,
1(2),
109
Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms-a whole of population study
Ta AD, Papa NP, Lawrentschuk N, Millar JL, Syme R, Giles GG, Bolton DM
(2015),
Prostate Int,
3(3),
75-9
Practical considerations in the selection of seed strength for prostate implants
Elliott SL, Beaufort CL, Millar JL
(2015),
J Appl Clin Med Phys,
16(5),
4720
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centre
Ong WL, Manohar P, Millar J, Royce P
(2015),
BJU Int,
116 Suppl 3,
5-10
Hypofractionated stereotactic radiotherapy for benign intracranial tumours of the cavernous sinus
Haghighi N, Seely A, Paul E, Dally M
(2015),
J Clin Neurosci,
22(9),
1450-5
Predictors of prostate cancer specific mortality after radical prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy Registry
Bolton DM, Papa N, Ta AD, Millar J, Davidson AJ, Pedersen J, Syme R, Patel MI, Giles GG
(2015),
BJU Int,
116 Suppl 3,
66-72
The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years
Roth H, Millar JL, Cheng AC, Byrne A, Evans S, Grummet J
(2015),
BJU Int,
116 Suppl 3,
49-53
A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism
Ballester F, Tedgren AC, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert F-A, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L
(2015),
Med Phys,
42(6),
3048-61
Prevalence of baseline erectile dysfunction (ED) in an Australian cohort of men with localized prostate cancer
Ong WL, McLachlan H, Millar JL
(2015),
J Sex Med,
12(5),
1267-74
The development of practice standards for radiation oncology in Australia: a tripartite approach
Kron T, Dwyer M, Smith L, MacDonald A, Pawsey M, Raik E, Arnold A, Hill B, Duchesne GM
(2015),
Clin Oncol,
27(6),
325-9
